Healthcare
Monday, March 28, 2016
Alder BioPharma's migraine drug succeeds in mid-stage study
March 28 (Reuters) - Alder BioPharmaceuticals Inc said on Monday its drug to prevent migraines had met the main goal in a keenly watched mid-stage study.
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment